Research AppraisalSystematic Review

Robot-assisted percutaneous pelvic channel screw placement for unstable pelvic ring injuries: a systematic review and meta-analysis with narrative technical comparison of multi-platform differences

Journal of robotic surgeryZhang, Wenhui, Zhang, Jinlong, Guo, Zhitao et al.27 May 2026DOI

Clinical Snapshot

80CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationAdult patients with unstable pelvic ring injuries requiring percutaneous channel screw fixation
I — InterventionRobot-assisted percutaneous pelvic channel screw placement (TiRobot, Mazor X, ROSA platforms)
C — ComparatorConventional fluoroscopy-guided percutaneous pelvic channel screw placement
O — OutcomesScrew accuracy (Gras classification), radiation exposure, operative time, functional recovery (Majeed score), complications, cost-effectiveness

Bottom Line

This meta-analysis of 15 studies demonstrates that robot-assisted pelvic screw placement significantly improves accuracy (OR 5.32) and reduces radiation exposure compared to conventional fluoroscopy, with comparable functional outcomes and fewer complications. However, evidence certainty is low due to predominant observational study designs and risk of bias. TiRobot has the strongest evidence base with 11 studies, while Mazor X and ROSA lack direct pelvic trauma validation. The technology shows promise for complex pelvic reconstructions but requires careful consideration of cost-effectiveness, surgeon training, and institutional capabilities. High-quality randomised trials and direct platform comparisons are urgently needed before widespread adoption can be recommended.

Evidence: Moderate

Key Findings

  • P Value: p < 0.001

  • Effect Size: OR = 5.32 for improved accuracy with robot assistance

  • Primary Outcome: Screw accuracy (excellent/good rate): 98.2% robot-assisted vs 86.4% conventional

  • Nnt Or Sensitivity: NNT = 9 patients (calculated from 11.8% absolute risk reduction in poor screw placement)

  • Confidence Interval: 95% CI: 3.18-8.89

Clinical Application

Limited by high acquisition costs, training requirements, and availability of robotic systems in trauma centres Relevant for major trauma centres; TGA approval status unclear for pelvic trauma applications; cost-effectiveness analysis needed for PBS consideration Adult patients with unstable pelvic ring injuries requiring percutaneous screw fixation in centres with robotic capability

Abstract

Percutaneous pelvic channel screw fixation is a key technique for the minimally invasive treatment of pelvic ring injuries. Robotic-assisted systems aim to improve accuracy and reduce radiation, but direct comparative studies across platforms are lacking. This systematic review and meta-analysis primarily compares robot-assisted versus conventional fluoroscopy-guided pelvic channel screw placement, with a secondary narrative comparison of technical differences across TiRobot, Mazor X, and ROSA platforms. We systematically searched PubMed, Web of Science, Embase, Cochrane Library, CNKI, Wanfang, and CBM databases up to April 2026. Comparative studies of robot-assisted versus conventional fluoroscopy-guided pelvic channel screw placement in adult pelvic ring injury patients were included. Primary outcomes were screw accuracy (Gras classification) and radiation exposure. Secondary outcomes included operative time, functional recovery (Majeed score), complications, and cost. No direct head-to-head studies comparing different robotic platforms for pelvic screw placement were identified; therefore, platform comparisons are primarily narrative and indirect, with spine surgery data presented as hypothesis-generating only. Risk of bias was assessed using ROBINS-I and RoB-2, and evidence was graded using the GRADE system. Fifteen studies (1,247 patients, 2,893 screws) were included. Primary meta-analysis showed that robot-assisted placement significantly improved screw accuracy (excellent/good rate: 98.2% vs. 86.4%; OR = 5.32, 95%CI: 3.18-8.89, p < 0.001; GRADE: Low certainty due to risk of bias) and reduced radiation exposure (SMD=-1.84, 95%CI: -2.43 to -1.25; GRADE: Low certainty due to serious inconsistency). Operative time showed no significant difference in studies by experienced surgeons (MD=-5.2 min, 95%CI: -11.0 to 0.6). Functional outcomes (Majeed score) were comparable between groups (MD = 0.8, 95%CI: -0.7 to 2.3). Overall complications were significantly reduced with robotic assistance (OR = 0.46, 95%CI: 0.30-0.71; GRADE: Low certainty due to risk of bias). For platform comparisons, TiRobot has the strongest pelvic trauma-specific evidence from 11 studies (847 patients). Evidence for Mazor X and ROSA in pelvic trauma is limited to technical descriptions and indirect spine surgery data; no direct pelvic trauma validation is available. Robot-assisted pelvic channel screw placement is superior to conventional methods in accuracy and radiation reduction, with comparable functional outcomes and fewer complications. TiRobot demonstrates the strongest pelvic trauma-specific evidence based on available comparative studies. Mazor X and ROSA require direct pelvic trauma validation before their performance can be reliably compared. TiRobot may have lower acquisition costs in Chinese healthcare settings, but formal cost-effectiveness analyses are lacking for all platforms. Significant evidence gaps remain, including lack of high-quality RCTs, absence of direct platform comparisons in pelvic trauma, and insufficient cost-effectiveness analyses.

References

  1. 1.Zhang, W., Zhang, J., Guo, Z., Yu, J., Yang, Y., Zhang, H., Ma, G., Chen, J., & Tai, H. (2026). Robot-assisted percutaneous pelvic channel screw placement for unstable pelvic ring injuries: a systematic review and meta-analysis with narrative technical comparison of multi-platform differences. Journal of Robotic Surgery. https://doi.org/10.3389/fsurg.2025.1594928
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service